Under the deal, New York-based Pfizer will charge most-favored-nation pricing to Medicaid and guarantee that pricing on newly launched drugs, Trump said. Lower drug prices also will help patients who have no insurance coverage and little leverage to negotiate better deals on what they pay. Trump has been talking for months about the need to lower drug prices and to boost U.S. drug manufacturing. Trump has claimed that the U.S., with its higher drug prices, subsidizes care in other countries. Drug prices for patients in the U.S. can depend on a number of factors, including the competition a treatment faces and insurance coverage.